SAMHD1 and cancer: As dNTP levels in cancer cells are 6 to 11-fold higher than that of normal cells (36), we hypothesized that cancer-associated SAMHD1 mutants would have reduced dNTPase activity, ultimately elevating intracellular dNTP levels.